Ina Lee

Dr. Ina Lee serves as an Assistant Research Physician in the Laboratory of Pathology at the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health. As a molecular pathologist within the NCI COMPASS program, she provides state-of-the-art clinical sequencing services to advance cancer research through genomic diagnostics.

Her academic training includes:

• M.D. and Ph.D. from the Medical Scientist Training Program at University of Illinois at Chicago School of Medicine
• Combined pathology residency (AP/CP) and hematopathology fellowship at University of Maryland Medical Center
• Molecular Genetic Pathology fellowship at University of North Carolina, Chapel Hill

Dr. Lee's research centers on genomic features of hematologic malignancies with specialized focus on integrated precision diagnostics for hematolymphoid neoplasms and myeloid neoplasm biology. She actively develops molecular testing frameworks that bridge genomic discoveries with clinical diagnostic applications, emphasizing multidisciplinary approaches to improve cancer detection and monitoring.

Her publication record demonstrates consistent contributions across oncology and molecular pathology, with recent work examining chromosomal abnormalities in leukemia progression, posttransplant lymphoma diagnostics, and viral pathogenesis mechanisms. This output reveals a strong trajectory in applying genomic technologies to solve clinical diagnostic challenges in blood cancers.

As a physician-scientist, Dr. Lee maintains dual roles in clinical diagnostics and translational research. Her position within the NCI intramural program indicates active participation in federally funded initiatives, particularly through the COMPASS sequencing platform that supports multiple research teams across the Center for Cancer Research.

Dr. Lee operates within the Laboratory of Pathology's collaborative ecosystem, leveraging advanced genomic technologies to address diagnostic challenges in hematologic malignancies. Her work exemplifies the NIH's mission to translate molecular discoveries into clinical applications through integrated diagnostic strategies.